Constitutive and interleukin-7/interleukin-15 stimulated DNA binding of Myc, Jun, and novel Myc-like proteins in cutaneous T-cell lymphoma cells

Blood

Volumn 93, Issue 1, 1999, Pages 260-267

  Qin, J Z ^a   Dummer, R ^a   Burg, G ^a   Dobbeling U ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 15; INTERLEUKIN 7; MYC PROTEIN; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIGENE FAMILY; ONCOGENE C JUN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DNA BINDING; SEZARY SYNDROME; T CELL LYMPHOMA;

EID: 0032947830     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.1.260     Document Type: Article

References (49)

1. Burg G, Kempf W, Häffner AC, Nestle FO, Hess Schmid M, Döbbeling U, Müller B, Dummer R: Cutaneous lymphomas. Curr Probl Dermatol 9:139, 1997
2. Saglio G, Emanuel BS, Guerrasio A, Giubellino MC, Serra A, Lusso P, Cambrin GR, Mazza U, Malavasi F, Pegorao L: 3′ c-myc rearrangement in a human leukemic T-cell line. Cancer Res 46:1413, 1986
3. Kanavaros P, Ioannidou D, Tzardi M, Datseris G, Katsantonis J, Delidis G, Tosca A: Mycosis fungoides: Expression of c-myc, p62, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 190:767, 1994
4. Leder P, Battey J, Lenoir G, Moulding C, Murphy W, Potter H, Stewart T, Taub R: Translocations among antibody genes in human cancer. Science 222:765, 1983
5. Piccoli SP, Caimi PG, Cole MD: A conserved sequence at c-myc oncogene chromosomal translocation breakpoints in plasmacytomas. Nature 310:327, 1984
6. Petroni D, Comi P, Giglioni B, Stacchini A, Martinotti G, Guerrasio A, Saglio G: Tumorigenic activity of a rearranged c-myc gene from a human T-cell leukemia line. Mol Cell Biol 13:883, 1992
7. Blackwood M, Eisenman RN: Max: A helix-loop-helix, zipper protein that forms a sequence-specific DNA-binding complex with myc. Science 251:1211, 1991
8. Amati B, Land H: Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 4:102, 1994
9. Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW: Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35:357, 1983
10. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD: L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318:69, 1985
11. Hirvonen H, Hukkanen V, Salmi TT, Pelliniemi TT, Alitalo K: L-myc and N-myc in hemapoietic malignancies. Leuk Lymphoma 11:197, 1993
12. Ingvarsson S, Asker C, Axelson H, Klein G, Sumegi J: Structure and expression of B-myc, a new member of the myc gene family. Mol Cell Biol 8:3168, 1988
13. Resar CM, Dolde C, Barrett JF, Dang CV: B-myc inhibits neoplastic transformation and transcriptional activation by c-myc. Mol Cell Biol 13:1130, 1993
14. Sugiyama A, Kume A, Nemoto K, Lee SY, Asami Y, Nemoto F, Nishimura S, Kuchino Y: Isolation and characterization of s-myc, a member of the rat myc gene family. Proc Natl Acad Sci USA 86:9144, 1989
15. Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong SH, Takamoto S, Nomura K, Matsutani M, Takakura K, Kuchino Y: Negative effects of wild type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J Neurooncol 19:259, 1994
16. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M: The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541, 1988
17. Rahmsdorf HJ: Jun: Transcription factor and oncoprotein. J Mol Med 74:725, 1996
18. Su B, Karin M: Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8:402, 1996
19. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729, 1987
20. Kovary K, Bravo R: Expression of different Jun and Fos proteins during the Go-to-G1 transition in mouse fibroblasts. Mol Cell Biol 11:2451, 1991
21. Kovary K, Bravo B: Existence of different Fos/Jun complexes during the Go-to-G1 transition and during exponential growth in mouse fibroblasts: In vitro and in vivo associations. Mol Cell Biol 12:5015, 1992
22. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S: Stimulation of B-cell progenitors by cloned murine IL-7. Nature 333:571, 1988
23. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson M, Watson JD, Anderson DM, Gin JG: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965, 1994
24. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483, 1995
25. Dalloul A, Laroche L, Bagot M, Mossalayi MD, Fourcade C, Thacker DJ, Hogge DE, Merle Béral H, Debré P, Schmitt C: Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest 90:1054, 1992
26. Döbbeling U, Dummer R, Laine E, Potoczna N, Qi J-Z, Burg G: IL-15 and IL-7 are growth factors for cutaneous T cell lymphoma cells. Blood 93:252, 1998
27. Matsue H, Bergstresser PR, Takashima A: Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J Immunol 151:6012, 1993
28. Mohamadzadeh M, Takashima A, Dougherty I, Knop J, Bergstresser PR, Cruz PD: Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J Immunol 155:4492, 1995
29. Blauvelt A, Asada H, Klaus-Kovtun V, Altman DJ, Lucey DR, Katz SI: Interleukin-15 mRNA is expressed by human keratinocytes, Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol 106:1047, 1996
30. Kaltoft K, Bisballe S, Rasmussen HF, Thesstrup-Pedersen K, Thomsen K, Sterry W: A continuous T-cell line from a patient with Sézary syndrome. Arch Dermatol Res 279:293, 1987
31. Kaltoft K, Holm-Hansen B, Thesstrup-Pedersen K: Cytogenetic findings in cell lines from cutaneous T cell lymphoma. Dermatol Clin 12:295, 1994
32. Kerl K, Sterry W: Classification and staging of cutaneous T cell lymphoma (CTCL), in Burg G (ed): Recommendations for Staging and Therapy of Cutaneous Lymphomas. EORTC/BMFT Cutaneous Lymphoma Project Group, Irsee, 1987, p 1
33. Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S, Burg G: Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-γ receptor β-chain). Blood 88:1383, 1996
34. Barberis A, Superti-Furga G, Busslinger M: Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with over-lapping sequences of a histone gene promoter. Cell 50:347, 1987
35. Gerber H-P, Georgiev O, Harshman K, Schaffner W: In vitro transcription complementation assay with mini extracts of transiently transfected COS-1 cells. Nucleic Acids Res 20:5855, 1992 36.Halazonetis TD, Kandil AN: Determination of the c-Myc DNA-binding site. Proc Natl Acad Sci USA 88:6262, 1991
36. Halazonetis TD, Kandil AN: Determination of the c-Myc DNA-binding site. Proc Natl Acad Sci USA 88: 6262, 1991
37. Grandori C, Eisenman RN: Myc target genes. Trends Biochem Sci 22:177, 1997
38. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B: Growth arrest by the cyclin-dependent kinase inhibtor p27 Kip1 is abrogated by c-Myc. EMBO J 15:6595, 1996
39. Jansen-Dürr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M: Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 90:3685, 1993
40. Galaktionov K, Chen X, Beach D: Cdc25 cell cycle phosphatase as a target of c-myc. Nature 371:257, 1996
41. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422, 1997
42. Castellazzi M, Spyrou G, La Vista N, Dangy J-P, Piu F, Yaniv M, Brun G: Overexpression of c-jun, junB, or junD affects cell growth differently. Proc Natl Acad Sci USA 88:8890, 1991
43. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M: Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76:747, 1994
44. Vandel L, Montrea N, Vial E, Pfarr CM, Binetruy B, Castellazzi M: Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun containing heterodimer is required for immortalization. Mol Cell Biol 16:1881, 1996
45. Kameda T, Akahori A, Sonobe MH, Suzuki T, Endo T, Iba H: JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2. Proc Natl Acad Sci USA 80:9369, 1993
46. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell AC: Transforming p21 ras mutants and Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270:23589, 1995
47. Nicolaides NC, Correa I, Casadevall C, Traval S, Soprano KJ, Calabretta B: The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an AP-1 like element. J Biol Chem 267:19665, 1992
48. Frampton J, Ramquist T, Graf T: V-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev 10:2720, 1996
49. Taylor D, Badiani P, Weston K: A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev 10:2732, 1996